Inge M. Ghobadi Moghaddam-Helmantel

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

Annemieke J.M. Nieuweboer, Shuiying Hu, Chunshan Gui et al. · Cancer Research · 2014 · 57 citations · Full text

Pharmaceutical Science, Polymer-drug Conjugate, Medicine +14

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Lisette Binkhorst, Ron H.J. Mathijssen, Inge M. Ghobadi Moghaddam-Helmantel et al. · Journal of Pharmaceutical and Biomedical Analysis · 2011 · 46 citations

Biochemistry, Medicine, Bioanalysis +11

Effects of CYP Induction by Rifampicin on Tamoxifen Exposure

Lisette Binkhorst, Teun van Gelder, Walter J. Loos et al. · Clinical Pharmacology & Therapeutics · 2012 · 40 citations

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

Sander A. Huisman, Peter de Bruijn, Inge M. Ghobadi Moghaddam-Helmantel et al. · British Journal of Pharmacology · 2015 · 37 citations · Full text

Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry

Peter de Bruijn, Inge M. Ghobadi Moghaddam-Helmantel, Maja J.A. de Jonge et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 22 citations

Bioanalytical Method, Biochemistry, Medicine +10